Canada · Biotechnology startup
Canada · Thryv Therapeutics
Thryv Therapeutics is a precision medicine approach to treat patients with Long QT Syndrome and potentially other arrhythmias.
Funding reportedLast round: Convertible Note
Follow Thryv Therapeutics and see its new rounds in your feed.Start following
What company datasets say Thryv Therapeutics raised
Funding, as reported
Reported in all40.3Min the source's currency
Last roundConvertible Note
Last round dateJun 2023
Founders and team
From Thryv Therapeutics's own website: 1 on the team.
- Justine KellerDirector, Finance
Biotechnology in Canada
Startups like it
- The Green Organic Dutchman HoldingsAncaster · founded 2012
HLS TherapeuticsCaledon · founded 2014- Chinook TherapeuticsVancouver · founded 2019
Acerta EnergyCalgary · founded 2013- Enobia PharmaMontreal · founded 1997
Abdera TherapeuticsVancouver · founded 2021
Kintara TherapeuticsVancouver · founded 2010
Cannara BiotechSaint Laurent · founded 2018
Is this your company?
Add your raise, your deck and your story, and put Thryv Therapeutics in front of investors. Or tell us what we have wrong.